Illumina Inc. and Tempus AI, Inc., a technology company leading the adoption of AI to advance precision medicine and patient care, announced a collaboration...
Tempus AI, Inc, a technology company leading the adoption of AI to advance precision medicine and patient care, announced a collaboration with Genialis, the...
Tempus, a leader in artificial intelligence and precision medicine, announced a collaboration with JW Pharmaceutical, one of the most established pharmaceutical companies in Korea,...
xM MRD and NeXT Personal Dx tests are now available for physicians in the U.S. for early cancer recurrence detection and residual disease monitoring
Tempus,...
Tempus, a leader in artificial intelligence and precision medicine, will present new data along with Pfizer at the AACR 2024 Annual Meeting. The abstract,...
Tempus, a leader in artificial intelligence and precision medicine, is broadly introducing its new Workspaces feature in the Lens platform. Workspaces is a private,...
Tempus, a leader in artificial intelligence and precision medicine, announced that the company has signed an agreement for in-network provider status with Cigna Healthcare....